The experience of palliative care service provision for people with non-malignant respiratory disease and their family carers: an all-Ireland qualitative study. by McVeigh, C. et al.
OR I G I N A L R E S E A R CH :
EM P I R I C A L R E S E A R CH—QUA L I T A T I V E
The experience of palliative care service provision for people
with non-malignant respiratory disease and their family
carers: An all-Ireland qualitative study
Clare Mc Veigh1 | Joanne Reid1 | Philip Larkin2 | Sam Porter3 | Peter Hudson1,4
1School of Nursing and Midwifery, Queen’s
University Belfast, Belfast, UK
2School of Nursing, Midwifery and Health
Systems, University College Dublin, Dublin,
Ireland
3Department of Social Sciences and Social
Work, Bournemouth University, Poole, UK
4St Vincent’s University Hospital and
University of Melbourne, Melbourne, Vic.,
Australia
Correspondence
Clare Mc Veigh, School of Nursing and
Midwifery, Queen’s University Belfast,
Belfast, UK.
Email: clare.mcveigh@qub.ac.uk
Funding information
This research received funding from the
Department of Employment and Learning,
Northern Ireland
Abstract
Aim: To explore specialist and generalist palliative care provision for people with
non-malignant respiratory disease, in rural and urban areas in the North and Repub-
lic of Ireland.
Background: Globally, palliative care is recommended as an appropriate healthcare
option for people with advanced non-malignant lung disease. Yet, there is limited
evidence regarding the integration of palliative care for this client group.
Design: Qualitative study.
Methods: Convenience sample of 17 bereaved carers and 18 healthcare profession-
als recruited from two rural and two urban sites on the Island of Ireland. Data were
collected throughout 2012 and 2013 through semi-structured interviews with carers
of patients with Chronic Obstructive Pulmonary Disease (N = 12), interstitial lung
disease (N = 4) or bronchiectasis (N = 1) who had died 3–18 months previously;
and four focus groups with healthcare professionals. Data were analysed using a
thematic analysis framework.
Results: Carers’ interviews yielded three overarching themes: (1) lack of preparedness
for death, due to ambiguity regarding disease trajectory; (2) lack of consistency in pal-
liative care delivery, in relation with the receipt of generalist and specialist palliative
care; and (3) role ambiguity, related to their caregiving role. Focus groups identified
two overarching themes: (1) barriers to appropriate palliative care; and (2) the future
direction of palliative care for patient with non-malignant respiratory disease.
Conclusion: The uncertain disease trajectory was not only experienced by carers
but also healthcare professionals. Although referral to specialist palliative care ser-
vices was perceived as increasing, the availability and coordination of generalist and
specialist palliative care services were fragmented and varied dependent on geo-
graphical location.
K E YWORD S
bronchiectasis, chronic obstructive pulmonary disease, COPD, family carers, interstitial lung
disease, non-malignant respiratory disease, nursing and healthcare professionals, palliative care,
qualitative research
Accepted: 4 August 2017
DOI: 10.1111/jan.13453
J Adv Nurs. 2017;1–12. wileyonlinelibrary.com/journal/jan © 2017 John Wiley & Sons Ltd | 1
1 | INTRODUCTION
Non-malignant respiratory disease (NMRD) is an umbrella term that
includes interstitial lung disease (ILD), bronchiectasis and chronic
obstructive pulmonary disease (COPD) (National End of Life Care
Intelligence Network 2011). Over 200 million people worldwide
have a diagnosis of COPD and while confirmability data are not
available, it is estimated that the extent of other chronic respiratory
diseases is a growing global health problem (World Health Organi-
sation (WHO) 2008). International guidelines emphasize the impor-
tance of generalist and specialist palliative care being made
available to patients with a respiratory illness (Bradley et al., 2008;
Lanken et al., 2008; NICE 2010, 2013; Raghu et al., 2011).
Research suggests however that patients with NMRD do not
receive the same standards of palliative care as patients with lung
cancer (Goodridge et al., 2008; Partridge, Khatri, Sutton, Welham,
& Afmedzai, 2009).
1.1 | Background
In 2014, the WHO and the Worldwide Palliative Care Alliance
(WPCA) published an atlas highlighting the global need for pallia-
tive care. This atlas highlighted that although palliative care pro-
grams have mainly focused on the needs of people with a
malignant disease in the past, the majority of those worldwide
needing palliative care have a non-malignant diagnosis. A key rec-
ommendation from the WHO and WPCA was that palliative care
should be integrated into relevant national health and disease-spe-
cific policies, a concept mirrored in the Palliative Care 2020
(2014) European Declaration on Palliative Care. Palliative Care
2020 additionally declared that new policies specific to palliative
care must include referral criteria to facilitate timely access to pal-
liative care based on the persons holistic needs, regardless of
diagnosis or prognosis.
There is clear symptom burden experienced by patients with
NMRD, such as dyspnoea, hypercapnia and anxiety, therefore pal-
liative care may mitigate against increased burden by the judicious
use of analgesics, antibiotics, O2 therapy and comfort care mea-
sures as appropriate. Generalist and specialist palliative service pro-
vision for patients with NMRD in the North and Republic of
Ireland (ROI) has been previously described (Mc Veigh, Reid, Larkin,
Porter, & Hudson, 2017). In NI, patients with COPD and their car-
ers expressed concerns about a variety of unmet holistic needs
(Hasson et al., 2008). Hasson et al. additionally highlighted that
patients with COPD experienced uncertainty regarding the trajec-
tory of their disease. Further evidence also depicted that carers of
patients with COPD had a range of unmet needs and can receive
inadequate support from the healthcare profession (Spence et al.,
2008). There is limited evidence however regarding palliative care
for patients with ILD or bronchiectasis, alongside COPD. Given this
background the research question guiding this study was: What are
the perceptions of bereaved carers and healthcare professionals
(HCPs) of the generalist and specialist palliative care service provi-
sion for people with NMRD, in rural and urban areas in the North
and ROI.
Why is this research needed?
• Internationally, palliative care is recommended for peo-
ple with non-malignant respiratory disease, yet the
integration of palliative care for this client group is
unclear.
• There is limited evidence regarding palliative care for
patients with interstitial lung disease or bronchiectasis,
alongside chronic obstructive pulmonary disease.
• There is limited research regarding the influence of geo-
graphical location on the provision of palliative care for
patients with non-malignant respiratory disease.
What are the key findings?
• The uncertain disease trajectory associated with non-
malignant respiratory disease and a lack of prognostic
information from healthcare professionals, resulted in a
lack of preparedness for death.
• The availability and coordination of generalist and
specialist palliative care services were fragmented
and varied dependent on geographical location, this
was not just isolated to rurality but also health jurisdic-
tion.
• Specialist and generalist palliative care services are
appropriate for patients with other forms of non-malig-
nant respiratory disease such as bronchiectasis and inter-
stitial lung disease, not just chronic obstructive
pulmonary disease.
How should the findings be used to influence
policy/practice/research/education?
• Future respiratory and palliative care policies should rein-
force amongst healthcare professionals the importance
of providing information regarding prognosis to this cli-
ent group and be effectively implemented in clinical
practice.
• Enhanced access to specialist and generalist palliative
care services is needed in areas with fewer services to
improve local palliative service provision.
• Palliative service provision should be inclusive of all
forms of non-malignant respiratory disease to address
the needs of patients with interstitial lung disease and
bronchiectasis, alongside chronic obstructive pulmonary
disease.
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2 | THE STUDY
2.1 | Aim
The aim of this study was to explore specialist and generalist pallia-
tive care provision for people with NMRD from the perspectives of
bereaved family carers and healthcare staff, in rural and urban areas
in the North and ROI.
2.2 | Design
This study employed a broad interpretivist qualitative enquiry to
facilitate an in-depth exploration of the intricacies of the topic being
investigated and to appropriately access the meanings and values
study participants applied to their experiences (Lapan, Quartaroli, &
Riemer, 2011).
2.3 | Participants
Recruitment for the interviews and focus groups has been
previously highlighted (Mc Veigh et al., 2017). Convenience
sampling was employed in this study. Sociodemographic details
about participants of the interviews and focus groups are
conveyed in Table 1. All participants were recruited across two
rural and two urban sites in the NI and the ROI (Figures 1 & 2).
Eligible participants targeted for the semi-structured interviews
were bereaved family carers, identified by a respiratory nurse
specialist as the main carer, of people with NMRD who had died
3–18 months previously. Participants were excluded if they were
under 18 years old, did not speak English or were too distressed
to take part in a research study. Eligible participants for the focus
groups included members of the multi-disciplinary team that
were involved in the generalist and specialist palliative care of
patients with NMRD and identified by relevant heads of each
department.
TABLE 1 Participant profiles
Participants of the semi-structured interviews
Gender
Women: 14 bereaved carers
Men: 3 bereaved carers
Age (years)
Mean: 58.2
Median: 55
Range: 41–81
Relation to patient
Daughter (N = 5)
Son (N = 2)
Wife (N = 7)
Partner (N = 1)
Daughter in-law (N = 1)
Nephew (N = 1)
Patient and carer living together
Yes (N = 10)
No (N = 7)
Occupation
Residential home manager (N = 1)
Unemployed (N = 3)
Retired (N = 6)
Classroom Assistant (N = 1)
Housewife (N = 3)
Probation Officer (N = 1)
Porter (N = 1)
Health and Safety Officer (N = 1)
Time post bereavement (months)
Mean: 7
Median: 6
Range: 4–17
Area
Northern Ireland (N = 10)
Republic of Ireland (N = 7)
Rural (N = 8)
Urban (N = 9)
Diagnosis
COPD (N = 12)
Interstitial lung disease (N = 4)
Bronchiectasis (N = 1)
Interview type
Face to Face (N = 10)
Telephone (N = 7)
Participants of the focus groups
Occupation
Specialist Palliative Care Occupational Therapist (N = 1)
Respiratory Nurse Specialist (N = 6)
(Continues)
Palliative Care Nurse Specialist (N = 3)
Consultant in Palliative Medicine (N = 1)
Specialist Palliative Care Nurse Consultant (N = 1)
Respiratory Consultant (N = 2)
Respiratory Ward Manager (N = 1)
Respiratory Deputy Ward Manager (N = 1)
Palliative Care Inpatient Unit Deputy Ward manager (N = 1)
Physiotherapist (N = 1)
Area
Northern Ireland (N = 11)
Republic of Ireland (N = 7)
Rural (N = 8)
Urban (N = 10)
TABLE 1 (Continued)
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2.4 | Data collection
Data were collected throughout 2012 and 2013. Semi-structured
interviews with caregivers (see Table S1) were conducted in par-
ticipants’ homes (N = 10), or over the telephone (N = 7) to allow
them to choose an interview method that was most convenient.
Interviews ranged from 22–80 min in length, with an average of
50 min. Focus groups (n = 4) with HCPs were conducted at each
site involved in the study (see Table S2). The focus groups ranged
from 68–81 min in length, with an average of 74 min. All
interviews and focus groups were digitally recorded and tran-
scribed verbatim. Interviews and focus groups were conducted by
the lead author who had appropriate training on conducting quali-
tative research. To aid accurate recording of focus groups, an
additional member of the research team fulfilled the role of note
taker. Data collection was completed when it was noted by the
researcher that no new themes or information were emerging
from the data.
2.5 | Data analysis
Data were analysed by adopting a thematic analysis framework
described by King and Horrocks (2010). To assist with managing the
data the qualitative research software package NVivo (Jupp, 2006) was
Total potential participants identified by gatekeepers (N = 30)
Envelopes containing documents outlined in section 3.5 distributed by
gatekeepers to potential participants (N = 30)
No Reply (N = 8)Consented to being 
contacted by the 
researcher (N = 17)
Declined to be 
contacted by the 
researcher (N = 5)
No Further 
Involvement
Telephone contact 
made by the 
researcher
No further 
Involvement
Agreed to participate 
in telephone 
interview (N = 7)
Agreed to participate 
in face-to-face 
interview (N = 10)
Not required as 
data saturation 
(N = 0)
Face-to-face 
interviews conducted 
(N = 10)
Interviews 
Cancelled (N = 0)
Telephone interviews 
conducted (N = 7)
Interview arranged, 
informed consent 
obtained
F IGURE 1 Flowchart of recruitment
and retention for semi-structured
interviews [Color figure can be viewed at
wileyonlinelibrary.com]
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used to provide the tools to support the management and categoriza-
tion of the qualitative data. Stage one of analysis was the assignment of
descriptive themes to sections of the data to describe their meaning.
Stage two encompassed grouping together descriptive themes to gen-
erate interpretative themes and highlight emerging patterns in the data.
The third stage of the framework required the identification of a num-
ber of overarching themes developed by pulling together and linking all
the interpretative themes that had been established. The overarching
and interpretative themes are outlined in Table S3.
2.6 | Ethical considerations
The ethical considerations of the study have been previously
described (Mc Veigh et al., 2014). Ethical approval was received from
the Office of Research and Ethics Committee NI (ORECNI, Refer-
ence: 11/NI/0166) and governance permission from the Northern
Health and Social Care Trust (Reference: NRP11-0264/09), Belfast
Health and Social Care Trust (Reference:11080JR-AS), Letterkenny
and Dublin. Written and verbal informed consent was obtained at
the time of interview or focus group.
2.7 | Rigour
Rigour of the study has been described previously (Mc Veigh et al.,
2014). Each transcription was initially analysed by the lead author
and then reviewed by the remaining research team to verify the
themes generated from the data collected.
3 | FINDINGS
Quotes are used as best exemplars from each theme. The anony-
mous participant codes and transcript page numbers for each quote
are also included.
Total potential participants identified by gatekeepers (N = 25)
Envelopes containing documents outlined in section 3.6 distributed by
gatekeepers to potential participants (N = 25)
Declined to be 
contacted by the 
researcher (N = 1)
No Reply (N = 6)Consented to being 
contacted by the 
researcher (N = 18)
No further 
Involvement
No Further 
Involvement
Telephone contact 
made by the 
researcher
Agreed to participate 
in focus group 
(N = 18)
Focus group 
scheduled, informed 
consent obtained
4 focus groups 
conducted (N = 6; 
N = 5; N = 3; N = 4)
F IGURE 2 Flowchart of recruitment
and retention for focus groups [Color
figure can be viewed at
wileyonlinelibrary.com]
VEIGH ET AL. | 5
3.1 | Semi-structured interviews findings
Analysis of the carers’ interviews identified three key overarching
themes: (1) lack of preparedness for death; (2) lack of consistency in
palliative care delivery; and (3) role ambiguity.
3.1.1 | Overarching theme (1) Lack of preparedness
for death
Participants expressed feelings of ambiguity in relation to the life
limiting nature of NMRD due to unpredictable disease trajectory.
The unpredictable nature of ILD, explained by a carer of a patient
with idiopathic pulmonary fibrosis (IPF), highlighted how quickly the
patient’s condition progressed and recalled their shock at this rapid
decline:
She deteriorated very quickly when she went into the hos-
pice I have to say. From going in and being able to walk
and look after herself very quickly it got to the stage
where she couldn’t walk and didn’t get dressed or any-
thing. She had gone downhill very rapidly when she went
home and then went back into the hospice. (BC4, p5)
Carers of patients with COPD or bronchiectasis expressed that
the patient’s condition appeared to deteriorate and then improve,
leading them to believe that the patient would always get better
again after becoming unwell:
You know a few Christmases ago he was rushed into hos-
pital on Christmas Eve and was really unwell and I saw
the wires and everything and thought this is serious. But
he pulled through. So it was a case of every time he went
into hospital the whole village just thought, ‘aw there he
goes back into hospital again he will be out by the week-
end.’ So we never expected him to die, to not come home.
Nobody expected it at all, my friends, nobody. (BC9, p4)
Carers additionally highlighted feelings of uncertainty about the
patient’s condition associated with a lack of information from HCPs
about the life-limiting nature of NMRD:
You know nobody ever told me how long he had left or
how long this was going to go on for and I feel now I
could have done with more information. Nobody ever
tells you, you are just left to your own imagination and
they just expect you to know but people don’t know.
Now I know a doctor can’t just turn around and tell you
the exact date he is going to last too but they could
have given me an indication that he wasn’t going to get
better and that it would only go on so long. They are
bound to know by the symptoms how long it is likely to
go on for. (BC14, p7)
Due to difficulties in gauging how the patient’s condition was
going to progress, participants were left feeling uncertain about the
staging of the patient’s illness. This led to feelings of
unpreparedness amongst participants when the patient’s condition
deteriorated.
3.1.2 | Overarching theme (2) Lack of consistency
in palliative care delivery
Carers’ accounts demonstrated a lack of consistency in the timing of
palliative care delivered to this client group. Carers expressed that
specialist palliative care was only introduced when the patient was
nearing the end of life and felt patients’ could have benefited from it
being introduced earlier:
We would have liked to have had more of the [specialist]
palliative care side of things earlier on rather than just
before he died. (BC15, p3)
In the ROI, results confirmed that patients with NMRD received
adequate support for their palliative needs in hospital. However, this
care was not continued when the patient was discharged back into
the community:
Well we felt that he could have definitely done with
more support at home to help him. But now when he
went into hospital the support he got there was brilliant,
the respiratory nurses and all were just brilliant. But
when he was discharged home the care just stopped, it
tapered off when he was discharged home from hospital.
(BC15, p2)
Carers additionally reported that the majority of patients with
NMRD in the ROI (N = 7) died in hospital (N = 6), rather than their
preferred place of death:
My partner would have ideally liked to come home
but. . .he did die in hospital. (BC16, p13)
In contrast with the views expressed by participants in the ROI,
findings highlighted that patients with NMRD in NI had sufficient
generalist palliative care to deal with their palliative needs in the pri-
mary care setting:
As her illness progressed they were there for her. You
know and obviously somebody was assessing to make
sure that was happening. And then they brought in the
machine for during the night and it was a very noisy
machine, so they put that in that it was upstairs in the
bedroom and also downstairs in the living room and so
you could tell as the illness progressed all the services
were being put in that she needed. (BC4, p4)
6 | VEIGH ET AL.
However, participants perceived that there was still insufficient
palliative care service provision experienced at home to facilitate
preferred place of death:
She did die in hospital, she did indeed and that’s part of
my hurt, calling the ambulance and letting her die in
there. She would have loved to have died at home. I
think that if we had have had more support at home
she could have died at home. (BC1, p10)
3.1.3 | Overarching theme (3) Role Ambiguity
Results illuminated carers’ feelings of ambiguity related to their care-
giving role. Participants felt confused as to why they were not
allowed to be involved in some conversations that took place
between the patient and the HCP:
Any of the other doctors didn’t mind when I stayed with
my husband to explain to him what they were saying
but she [the doctor] wouldn’t let me stay. And it was
always, ‘you wait out in the corridor and I will speak to
you in a few minutes. (BC3, p4)
Carers’ expressed that the knowledge they acquired whilst caring
for a patient at home was not acknowledged in the inpatient setting:
When I went to refill the machine [non-invasive ventila-
tion machine] with water there was a nurse practitioner
there and she went through me for touching the
machine and I was very angry as I knew just as much
about operating the bloody machine as she did. (BC2,
p8)
Role ambiguity was also exemplified by participants’ conclusions
that they had a lack of support from the healthcare profession and
therefore had no choice but to take up the role of carer:
You know it ended up being me and my sister that would
have went up a lot to see him and help him out because
we didn’t have any other support. A lot of the pressure
was put on ourselves to look after him. (BC15, p3)
Carers additionally revealed that certain HCPs depended on
them to provide guidance on how to deliver certain elements of care
to the patient, such as non-invasive ventilation:
I went to for a holiday on the Wednesday and I had no
sooner arrived than I got a phone call saying ‘this is the
nursing home here something is wrong with the nippy
machine can you come and fix it?’ I then had to spend
the next couple of hours sending texts to the nippy rep
and she actually went to the nursing home to sort it
out. (BC2, p3)
3.2 | Focus group findings
Analysis of the HCP focus groups yielded two key overarch-
ing themes: (1) barriers to providing appropriate palliative care and
(2) the future direction of palliative care for patients with NMRD.
3.2.1 | Overarching theme (1) Barriers to providing
appropriate palliative care
Participants across NI and the ROI described an inability to provide
timely palliative care to patients with NMRD due to difficulties in
identifying the patient’s prognosis. For patients with COPD and
bronchiectasis, findings indicated that prognostic uncertainty was
related to the patient having multiple episodes of becoming very
unwell and then their condition improving:
With lung cancer patients you can give a rough progno-
sis and know when to introduce palliative care. With
patients with COPD there is no definitive timeline and
they can be up and down so there is no obvious point
where you know to definitely involve palliative care so
that is the big issue really. (RN8, Respiratory Deputy
Ward Manager, p8)
Healthcare professionals expressed that with a diagnosis of IPF it
was easier to identify when the patient’s condition was deteriorat-
ing:
Certainly in pulmonary fibrosis (ILD) it is fairly clear as
there is a clearly defined decline and there is a life
expectancy attached to the diagnosis. So I think we are
better at recognizing they are palliative than we were
certainly but there are some improvements still to be
made. (RC2, Respiratory Consultant, p14)
However, participants also recognized that an inadequate under-
standing amongst HCPs of the role of palliative care in NMRD cre-
ated barriers to providing appropriate palliative care:
Well there are people who won’t refer to palliative care
and you will find it has a lot to do with their own hang
ups about what palliative care really is and their own
lack of understanding. (PCN5, Palliative Care Nurse Spe-
cialist, p7)
Participants in NI held the view that specialist palliative care was
available equally to patients with COPD, bronchiectasis and ILD.
However HCPs in the ROI indicated an inequality in the provision of
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specialist palliative care to patients with ILD or bronchiectasis, com-
parative to those with COPD:
I suppose from what I have seen it is mostly COPD
patients that get seen by specialist palliative care and I
haven’t had any bronchiectasis patients that have been
seen or referred to specialist palliative care that I am
aware of. (PH, Physiotherapist, p8)
Throughout NI and the ROI, the lack of availability of
generalist and specialist palliative care services in rural areas to
patients with NMRD, in comparison to those in urban settings,
was highlighted:
In particular in the really rural areas they are particularly
bad spots and we have major issues getting packages of
care for anywhere around really rural areas. You just
cringe when you hear someone’s address is there and
you just hope that they don’t need a package because it
is very, very difficult to get one. Even if they are end of
life care it’s still extremely difficult because the services
are just not available. (PCN3, Palliative Care Inpatient
Unit Deputy Ward Manager, p13)
I think as well with the specialist palliative care services
there maybe aren’t as many available to NMRD patients
in the more rural areas as there are in urban areas.
(PCN5, Palliative Care Nurse Specialist, p10)
3.2.2 | Overarching theme (2) The future direction
of palliative care for patients with NMRD
Throughout NI and the ROI, HCPs conveyed that the presence of
specialist palliative care providers in the care of patients with NMRD
was increasing:
The balance has changed because with our post [special-
ist palliative care OT] about 7 years ago there would
have been the expectation that it would 90:10 malig-
nant versus non-malignant disease but it has changed
and I would say we are fast approaching a 75% case
load for malignant and the rest are non-malignant just
made up of neurology or respiratory. (OT1, Specialist
Palliative Care Occupational Therapist, p3)
The increased referrals to specialist palliative care services were
perceived as being a result of specialist palliative care providers
being more accepting of patients who have a non-malignant
diagnosis:
Now all hospices are open to take non-malignant refer-
rals which are great and they are much more eager to
fill that role than they were previously. (PCN5, Palliative
Care Nurse Specialist, p4)
In NI the presence of a regional model to guide the implementa-
tion of palliative care, dependant on stage of illness, was used by
HCPs caring for patients with NMRD to ensure they received opti-
mal palliative care:
Well there is the ELCOS (End of Life Care Operational
System) Model for palliative care used for respiratory
palliative care and that is regional and it moves from
early to late phase and tells you what the patient should
be getting at each stage. And I suppose with the model
everything is there and you know what’s available and
what you should be doing and us a team can look and
see what we need to be doing. (RN2, Respiratory Nurse
Specialist, p14)
In the ROI however, participants acknowledged the lack of a
regional model for palliative care that could help to guide the deliv-
ery of care to patients with NMRD:
We don’t have a model for either delivering palliative
care or respiratory care and I suppose we should. (RN5,
Respiratory Nurse Specialist, p8)
The role of the carer was acknowledged and great emphasis was
placed on the importance of meeting the carer’s information needs
regarding the patient’s condition:
Carers are slightly different, carers are different from
patients. I think that quite often the carer has to have a
clear picture of what is going on . . . if you have a carer
you would often say, you know, ‘It is very, very severe
lung disease and they may not survive this illness.’ And
that is a conversation that I often have very frequently
with people. The carers are very keen to know how sev-
ere their relative is and the relative will be told that they
have severe lung disease and let them ask what they
want to know after that. There can be people [patients]
who are devastated and don’t want to know and yet the
relatives have to know a little bit more of the gritty real-
ity of, ‘This is really tough stuff here and they are really
unwell. (RC1, Respiratory Consultant, p21)
The well-being of the carer had an impact on the patient’s expe-
rience as for patients with NMRD to be successfully cared for at
home the carer needed adequately supported:
I think you have to have the carers on board as well
because a lot of home management systems fail not
because of the patient but because of the carer. You
know trying to get someone home because ‘Transforming
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Your Care’ [2011 review of health and social care in NI]
says that more people should have the chance to die at
home but often it is the carer that you see totally wide
eyed with fear when their loved one says that they want
to go home and they sort of think ‘how do I manage
this?’ So I think the support to the carer is hugely impor-
tant, although you focus on the patient you have to give
just as much support to the carer. (RC2, Respiratory
Consultant, p22)
4 | DISCUSSION
Carers’ accounts concurred with previous research as they high-
lighted how the uncertain COPD trajectory resulted in ambiguity
regarding disease progression amongst patients and carers (Hynes,
Stokes, & Mc, 2012; Pinnock et al., 2011). Similarly, bronchiectasis
caused uncertainty regarding the disease trajectory due to the
patient’s fluctuation between periods of illness and wellness. How-
ever ILD caused prognostic uncertainty through displaying a trajec-
tory where the patient’s condition was perceived as being stable and
then rapidly deteriorating after experiencing no exacerbations to
their condition. Previous research suggested that the deterioration in
patients with ILD helped patients and carers understand that the
condition was palliative (Bajwah et al., 2012). Conversely, our study
reported that patients with ILD and their carers were unprepared for
this rapid deterioration and it did not provide further clarity into the
life-limiting nature of the disease. Carers perceived a lack of aware-
ness regarding the patient’s prognosis was also caused by a lack of
information from HCPs regarding the palliative nature of NMRD.
This adds to previous research which has highlighted that patients
with COPD often get to the stage in their illness where they require
regular oxygen therapy and are still unaware they have a palliative
illness, due to a lack of information about the life limiting nature of
their disease (Gott et al., 2009; Lowey, Norton, Quinn, & Quill,
2013). The present study highlighted a lack of death preparedness
(Pincombe, Brown, Thorne, Ballantyne, & Mc Cutcheon, 2000)
amongst not only patients with COPD and their carers, but also
those with bronchiectasis and ILD. Death preparedness can be
defined as the readiness for death (Hebert, Prigerson, Schulz, &
Arnold, 2006) experienced by the patient and their carer. A con-
tributing factor to being prepared for death is also an awareness of
dying (Mc Leod-Sordjan, 2014), however, the present study high-
lighted how, alongside COPD, patients with bronchiectasis and ILD
were unaware of the life limiting nature of the disease and that the
patient would die from the disease.
Findings additionally demonstrated that, alongside carers, HCPs
found a lack of prognostic certainty in relation to NMRD that
resulted in difficulties determining disease progression. This aligned
with previous research highlighting that prognostic uncertainty
caused HCPs to experience difficulties in effectively managing
patients with advanced COPD and recognizing when their condition
was declining (Pinnock et al., 2011; Spence et al., 2008). Our find-
ings further highlighted that this is not isolated to COPD as HCPs
perceptions also associated prognostication difficulties with
bronchiectasis. Conversely findings highlighted that, unlike carers,
HCPs perceived that it was easier to identify the prognosis of a
patient with ILD due to clear prognostic indicators. Previous
research in the UK (Bajwah et al., 2012) appears to align with our
findings, highlighting that HCPs may not have provided patients with
ILD and their carers with appropriate prognostic information.
Inequalities in the provision of palliative care across the island
of Ireland can be influenced by geographic location (DHSSPSNI
2011, Joint Oireachtas Committee on Health and Children 2014,
Murray, Mc Loughlin, & Foley, 2013) and was evidenced in the
present study. Findings aligned with previous research as HCPs
perceived that palliative care services were limited for patients liv-
ing in rural areas (Goodridge, Lawson, Rennie, & Marciniuk, 2010;
Robinson et al., 2009). The present study highlighted however that
the influence of geographical location on palliative care for NMRD
was not solely dependent on rurality. Findings concurred with pre-
vious research highlighting disparities between the availability of
generalist and specialist palliative care services in the primary care
setting across Europe (Lopez-Campos, Asensio-Cruz, Castro-Acosta,
Calero, & Pozo-Rodriguez, 2014). Our study however illuminated
perceptions that patients with NMRD in the ROI had limited
access to palliative care services in the primary care setting, in
comparison with NI. Patients with COPD can have several read-
missions to hospital caused by a lack of follow-up care in the
community post discharge (Jeffs, Dhalla, Cardoso, & Bell, 2014).
Present findings additionally highlighted that the lack of services
in the primary care setting in the ROI for patients with ILD and
bronchiectasis, alongside COPD, may have influenced their place
of death. This demonstrated how patients’ geographical location
and the palliative care services available in this location, potentially
had an impact on whether or not they died in their preferred
place of care.
Previous research has identified models of palliative care for
patients with ILD and COPD, advocating the introduction of special-
ist palliative care early in a patient’s disease trajectory (Higginson
et al., 2014) or when a patients’ symptom management becomes too
complex for generalists to manage (Strang, Ekberg-Jansson, Strang, &
Larsson, 2013). In the present study participants perceived that spe-
cialist palliative care services were not involved with the majority of
patients, concurring with previous findings related to patients with
ILD (Bajwah et al., 2012; Lindell et al., 2014) and COPD (Beernaert
et al., 2013). We additionally discovered that patients with
bronchiectasis also experienced a lack of involvement from specialist
palliative care providers. Carers’ accounts highlighted that patients
with NMRD and their carers wanted access to these services how-
ever service availability was often uncoordinated and varied. HCPs
however perceived that referrals to specialist palliative care for
patients with NMRD are increasing. Results conveyed that this may
be equated to increased acceptability of the role of specialist pallia-
tive care for patients with non-malignant conditions.
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Carers referred to feelings of role ambiguity caused when they
felt excluded from elements of the patients care, but also high-
lighted how HCPs depended on the carer. Previous research in the
UK highlighted that carers of patients with COPD felt unprepared
for their role and often felt isolated, due to a lack of bio-psychoso-
cial support from HCPs (Spence et al., 2008). We additionally
ascertained that carers of patients with ILD and bronchiectasis,
alongside COPD, also felt isolated when not included in the deliv-
ery of some elements of the patients care, especially in the sec-
ondary care setting. HCPs’ perceptions aligned with the view that
more effective carer assessments are required that would enable
the appropriate identification of the needs and concerns of carers
of patients with NMRD.
These findings have implications for clinical practice, policy and
research. A key recommendation from regional palliative care guideli-
nes was the timely provision of information to patients with a life-
limiting illness and their carers regarding their illness (DHSSPSNI
2010). However, findings demonstrated that the recommendations
of these palliative and end of life care strategies often may not be
implemented by HCPs caring for patients with NMRD. Future respi-
ratory and palliative care policies need to reinforce amongst HCPs
the importance of providing information regarding prognosis and
prognostic difficulties, to patients with NMRD and be effectively
implemented in clinical practice.
The National Respiratory (COPD) Framework (Irish Thoracic Soci-
ety, Health Service Executive & Royal College of General Practition-
ers, 2008) recognized the need for patients in the ROI with COPD
to have access to multidisciplinary teams that included specialist pal-
liative care input and this is available in the North and ROI (Belfast
Health and Social Care Trust 2015; Murray et al., 2013, Northern
Health and Social Care Trust 2015). However the present study and
previous evidence (Murray et al., 2013), has highlighted that the
availability and coordination of these services are fragmented and
can be varied dependant on geographical location. Enhanced avail-
ability of these services would afford generalist palliative care provi-
ders in areas with fewer services to have rapid access to specialist
support and advice. Whilst previous evidence referred only to
patients with COPD and ILD (Irish Thoracic Society, Health Service
Executive & Royal College of General Practitioners, 2008), the pre-
sent study identified the need for these services to also filter down
to patients with bronchiectasis.
To provide further evidence regarding the reasons for patients
and carers lack of awareness regarding the life-limiting nature of
NMRD, future research could explore the quality of palliative and
end of life discussions with patients with NMRD and their carers.
Previous research has explored these discussions with patients with
COPD (Leung, Udris, Uman, & Au, 2012), however, further investiga-
tion amongst patients with ILD and bronchiectasis, alongside COPD,
that also includes the carer is warranted. A quantitative study that
aims to investigate the quality of palliative and end of life care dis-
cussions between HCPs and patients with NMRD and their carers,
through the previously validated Quality of Communication Tool
(Curtis et al., 2008) could be conducted.
4.1 | Limitations
Eighteen HCPs were recruited into the study however the majority
who participated were nurses (N = 13). Increased numbers of allied
HCPs and medical staff may have provided more diverse perspec-
tives. The majority of carers who participated in the study (N = 17)
had cared for someone with COPD (N = 12) and only a small num-
ber of participants had cared for someone with ILD (N = 4) or
bronchiectasis (N = 1). Recruiting greater numbers from the other
two disease groups may have provided further perspectives. Findings
also only represented the perspectives of carers and HCPs and not
the patient’s own perspective.
5 | CONCLUSION
This study illuminated the challenges patients, carers and HCPs
encountered due to the uncertain NMRD trajectory and how this
had an impact on death preparedness and the receipt of palliative
care. The availability and coordination of specialist and generalist
palliative care services for patients with NMRD is fragmented and
varied dependant on geographical location. Enhanced availability of
these services would afford HCPs in areas with fewer services to
have rapid access to specialist support and advice. To reduce
inequalities in the provision of palliative care for NMRD, related to
geographical location, service development measures must be put in
place that are inclusive of patients with ILD and bronchiectasis. The
management of patients with NMRD is complex and challenging
with a clear need for a stronger and more integrative model of prac-
tice, incorporating palliative care in a responsive and dynamic way.
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